TC |
Stat |
Stk |
Ins |
Fil |
+d |
+w |
+m |
+q |
+h |
+y |
avg |
|---|
Filing Date |
T Date |
Ticker |
Issuer | Inc | Sector |
Ind | Industry |
Owner |
oSt |
Rel |
Title |
T |
TVal |
Price |
L |
Qty |
oc |
Own |
H |
r2y |
r1y |
r6m |
r3m |
r6w |
r3w |
r7d |
r3d |
f1d |
f1w |
f1m |
f3m |
f6m |
f1y |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
12/11/14 16:31 | 12/10/14 | CVD | Covance Inc | DE | Health | Biolab | Commercial Physical & Biologi | Watson John E. | NJ | O | Corp. SV | M.d | 1,036 | 48.99 | 0 | 21 | 44 | 69 | D | ||||||||||||||
12/11/14 16:31 | 12/10/14 | CVD | Covance Inc | DE | Health | Biolab | Commercial Physical & Biologi | Watson John E. | NJ | O | Corp. SV | S.d | -1,565 | 102.94 | 0 | -15 | -18 | 69 | D | ||||||||||||||
12/9/14 16:56 | 12/5/14 | CVD | Covance Inc | DE | Health | Biolab | Commercial Physical & Biologi | Watson John E. | NJ | O | Corp. SV | M.d | 1,101 | 61.07 | 0 | 18 | 40 | 64 | D | ||||||||||||||
12/9/14 16:56 | 12/5/14 | CVD | Covance Inc | DE | Health | Biolab | Commercial Physical & Biologi | Watson John E. | NJ | O | Corp. SV | S.d | -1,497 | 103.21 | 0 | -15 | -19 | 64 | D | ||||||||||||||
2/18/14 16:11 | 2/13/14 | CVD | Covance Inc | DE | Health | Biolab | Commercial Physical & Biologi | Watson John E. | NJ | O | Corp. SV | M.d | 671 | 48.12 | 0 | 14 | 38 | 51 | D | ||||||||||||||
2/18/14 16:11 | 2/13/14 | CVD | Covance Inc | DE | Health | Biolab | Commercial Physical & Biologi | Watson John E. | NJ | O | Corp. SV | S.d | -1,403 | 100.64 | 0 | -14 | -21 | 51 | D |
| D | Derivative transaction in filing (usually option exercise) |
| M | Multiple transactions in filing; earliest reported transaction date and weighted average transaction price |
| A | Amended filing |
| E | Error detected in filing |
| S - Sale | Sale of securities on an exchange or to another person |
| S - Sale+OE | Sale of securities on an exchange or to another person (after option exercise) |
| F - Tax | Payment of exercise price or tax liability using portion of securities received from the company |
| P - Purchase | Purchase of securities on an exchange or from another person |